The biotechnology research and experimental development sector in Germany is projected to expand steadily from 2024 to 2028. Starting at 886 enterprises in 2024, the industry is expected to reach 956 enterprises by 2028. From 2023 to 2024, the market witnesses a continuation of growth observed in previous years. The year-on-year increase in the number of enterprises remains consistent, contributing to a robust sector with a Compound Annual Growth Rate (CAGR) illustrating positive momentum.
Key future trends to watch include:
- Technological advancements that could accelerate research capabilities.
- Increasing collaborations between academic and commercial entities.
- Government policies promoting research and development investments.
- Potential impact of global market dynamics on domestic research initiatives.
